Outcomes and healthcare-associated costs one year after intensive care-treated cardiac arrest

Autor: Markus B. Skrifvars, Ilmar Efendijev, Daniel Folger, Matti Reinikainen, Pirkka T. Pekkarinen, Erik Litonius, Rahul Raj
Přispěvatelé: Department of Diagnostics and Therapeutics, University of Helsinki, Anestesiologian yksikkö, Clinicum, HUS Perioperative, Intensive Care and Pain Medicine, HUS Neurocenter, Neurokirurgian yksikkö, Department of Neurosciences, HUS Emergency Medicine and Services
Rok vydání: 2018
Předmět:
Male
Cardiac arrest location
Survival
Cost effectiveness
Cost-Benefit Analysis
medicine.medical_treatment
EUROPEAN-RESUSCITATION-COUNCIL
Comorbidity
030204 cardiovascular system & hematology
Emergency Nursing
STROKE-FOUNDATION
0302 clinical medicine
Healthcare associated
AMERICAN-HEART-ASSOCIATION
UTSTEIN STYLE
Survivors
Hospital Costs
Finland
Outcome
OF-LIFE
Age Factors
Middle Aged
Cardiac arrest
3. Good health
Neurological outcome
Intensive Care Units
Emergency Medicine
Population study
Female
Cardiology and Cardiovascular Medicine
Adult
Utstein Style
medicine.medical_specialty
03 medical and health sciences
Intensive care
medicine
Humans
RATES
Cardiopulmonary resuscitation
Aged
Retrospective Studies
business.industry
LONG-TERM SURVIVAL
030208 emergency & critical care medicine
Retrospective cohort study
Length of Stay
Healthcare costs
3126 Surgery
anesthesiology
intensive care
radiology
Long-term outcome
CARDIOPULMONARY-RESUSCITATION
Emergency medicine
Cost-effectiveness
business
Out-of-Hospital Cardiac Arrest
SYSTEM
TASK-FORCE
Zdroj: Resuscitation. 131:128-134
ISSN: 0300-9572
Popis: Correction Volume: 133 Pages: 193-193 DOI: 10.1016/j.resuscitation.2018.09.022 Published: DEC 2018 Background: Despite the significant socioeconomic burden associated with cardiac arrest (CA), data on CA patients' long-term outcome and healthcare-associated costs are limited. The aim of this study was to determine one-year survival, neurological outcome and healthcare-associated costs for ICU-treated CA patients. Methods: This is a single-centre retrospective study on adult CA patients treated in Finnish tertiary hospital's ICUs between 2005 and 2013. Patients' personal identification number was used to crosslink data between several nationwide databases in order to obtain data on one-year survival, neurological outcome, and healthcare-associated costs. Healthcare-associated costs were calculated for every patient stratified by cardiac arrest location (OHCA = out-of-hospital cardiac arrest, IHCA = all in-hospital cardiac arrest, ICU-CA = in-ICU cardiac arrest) and initial cardiac rhythm. Cost-effectiveness was estimated by dividing total healthcare-associated costs for all patients from the respective group by the number of survivors and survivors with favourable neurological outcome. Results: The study population included 1,024 ICU-treated CA patients. The sum of costs for all patients was (sic)50,847,540. At one-year after CA, 58% of OHCAs, 44% of IHCAs, and 39% of ICU-CAs were alive. Of one-year survivors 97% of OHCAs, 88% of IHCAs, and 93% of ICU-CAs had favourable neurological outcome. Effective cost per one-year survivor was (sic)76,212 for OHCAs, (sic)144,168 for IHCAs, and (sic)239,468 for ICU-CAs. Effective cost per one-year survivor with favourable neurological outcome was (sic)81,196 for OHCAs, (sic)164,442 for IHCAs, and _(sic)257,207 for ICU-CAs. Conclusions: In-ICU CA patients had the lowest one-year survival with the effective cost per survivor three times higher than for OHCAs.
Databáze: OpenAIRE
Externí odkaz: